Related Experiment Video
Updated: May 8, 2026

Identification of Orexin and Endocannabinoid Receptors in Adult Zebrafish Using Immunoperoxidase and Immunofluorescence Methods
Published on: June 25, 2019
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey1, Nadezhda A German, Brian P Gilmour
1Research Triangle Institute , Research Triangle Park, North Carolina 27709, United States.
Abstract:
Increasing evidence implicates the orexin 1 (OX1) receptor in reward processes, suggesting OX1 antagonism could be therapeutic in drug addiction. In a program to develop an OX1 selective antagonist, we designed and synthesized a series of substituted tetrahydroisoquinolines and determined their potency in OX1 and OX2 calcium mobilization assays. Structure-activity relationship (SAR) studies revealed limited steric tolerance and a preference for electron deficiency at the 7-position. Pyridylmethyl groups were shown to be optimal for activity at the acetamide position. Computational studies resulted in a pharmacophore model and confirmed the SAR results. Compound 72 significantly attenuated the development of place preference for cocaine in rats.
Insights
Selective OX1 receptor antagonists may treat drug addiction. Researchers developed novel tetrahydroisoquinoline compounds, with Compound 72 showing promise by reducing cocaine-induced place preference in rats, indicating therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- The orexin 1 (OX1) receptor is increasingly implicated in reward pathways.
- OX1 receptor antagonism presents a potential therapeutic strategy for substance use disorders.
Purpose of the Study:
- To design and synthesize novel OX1 selective antagonists.
- To investigate the structure-activity relationships (SAR) of tetrahydroisoquinoline derivatives for OX1 antagonism.
- To evaluate the efficacy of a lead compound in a preclinical model of drug addiction.
Main Methods:
- Synthesis of substituted tetrahydroisoquinoline compounds.
- In vitro evaluation using OX1 and OX2 calcium mobilization assays.
- Structure-activity relationship (SAR) analysis and computational modeling.
- In vivo assessment of cocaine-induced place preference in a rat model.
Main Results:
- SAR studies identified key structural requirements for OX1 receptor antagonism, including limited steric tolerance and electron deficiency at the 7-position.
- Pyridylmethyl groups at the acetamide position were optimal for activity.
- A pharmacophore model was developed, consistent with SAR findings.
- Compound 72 demonstrated significant attenuation of cocaine-induced place preference in rats.
Conclusions:
- Novel tetrahydroisoquinoline derivatives were successfully designed and synthesized as selective OX1 antagonists.
- Compound 72 exhibits preclinical efficacy in a cocaine addiction model.
- These findings support the development of OX1 antagonists as a potential treatment for drug addiction.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Opioid Receptors: Overview
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antipsychotic Drugs: Typical and Atypical Agents

